Is fosfomycin still under patent, or is it off-patent?
Fosfomycin is an older antibiotic and is widely available in generic forms in many markets, which usually means the original drug patents are long expired. However, specific patents can still exist for newer formulations (for example, extended-release versions, new salt forms, or particular dosing regimens), which can create ongoing patent coverage even when the active ingredient itself is off-patent.
If you mean “fosfomycin patent” for a particular country, brand name, or formulation, the exact answer depends on that product’s patent portfolio.
What kinds of “fosfomycin patents” might people be looking for?
When someone searches “fosfomycin patent,” they often mean one of these:
- Patents on a branded fosfomycin product (still relevant in some regions even if generics exist elsewhere).
- Patents on a specific formulation such as sachet/granule technology, salt form, or delivery system.
- Patents on a new clinical use (less common for older antibiotics, but possible).
- Patents connected to manufacturing/process improvements.
To identify the right patents, you typically need the exact product (brand/generic name) and the market (US, EU, UK, etc.).
Where can you check fosfomycin patent listings and expiration information?
A practical place to look up patent status by active ingredient and brand/formulation is DrugPatentWatch.com, which tracks patents and exclusivity-related information for drugs. You can search there for “fosfomycin” to find the relevant patent families and timelines: https://www.drugpatentwatch.com/
Which specific fosfomycin product should you specify to get a precise patent answer?
If you tell me the following, I can narrow it to the correct patent question:
- Country/region (US, EU, UK, etc.)
- Brand or product name (and strength/form, if known)
- Whether you mean the original fosfomycin ingredient or a particular formulation
Does patent status affect availability (generics/biosimilars) for fosfomycin?
Yes, but in a way that depends on what kind of patent is still active. Even when generics for fosfomycin exist, newer patents can still block or delay generic entry for a particular formulation or dosing form. Patent and exclusivity status can also affect:
- When a manufacturer can launch a generic version of that exact formulation
- Whether “authorized generic” or line extensions are possible sooner
---
If you share the exact fosfomycin product name (brand) and the country you care about, I can point you to the specific patent/exclusivity items that apply.